From Medscape Nephrology

Kidney Week 2016: American Society of Nephrology Annual Meeting

November 15 - 20, 2016; Chicago, Illinois

November 15 - 20, 2016 Chicago, Illinois

Kidney Week Dual-Pathway Inhibitor Targets Glomerular Disease A hypertension drug might benefit patients with primary focal segmental glomerulosclerosis, a rare kidney disease characterized by proteinuria, suggest early results from the DUET trial.
Medscape Medical News, November 28, 2016
Kidney Week Novel Regimen Showing Promise, a First in Lupus Nephritis An induction regimen that includes a calcineurin inhibitor can help patients with acute lupus nephritis achieve complete or partial remission, early research suggests.
Medscape Medical News, November 21, 2016

Kidney Week Dual-Pathway Inhibitor Targets Glomerular Disease
Medscape Medical News, November 28, 2016
Kidney Week Rapid Steroid Withdrawal Cuts Diabetes After Transplant
Medscape Medical News, November 21, 2016
Kidney Week Novel Regimen Showing Promise, a First in Lupus Nephritis
Medscape Medical News, November 21, 2016

Kidney Week Program Helps With Transition to Renal Replacement Therapy
Medscape Medical News, November 18, 2016
Kidney Week Renal Outcomes in Diabetes Leading Kidney Week
Medscape Medical News, November 9, 2016

More Red Meat Increases Risk for End-Stage Renal Disease There is a positive association between the consumption of red meat and the risk for end-stage renal disease, but the risk is significantly lower when other sources of protein are consumed.
Medscape Medical News, Nov 13, 2015
Wearable Artificial Kidney Potential Alternative to Dialysis A third trial supported the efficacy and safety of a wearable artificial kidney in patients receiving hemodialysis, opening the door to a new lease on life for patients with end-stage renal disease.
Medscape Medical News, Nov 7, 2015
Big Trials Disappoint at Kidney Week The mystifying relation between vascular complications and kidney disorders has investigators stumped after negative results from three highly anticipated trials of statins, steroids, and fish oils.
Medscape Medical News, Nov 11, 2015

Medscape Nephrology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Medscape Board at the Podium

Rajiv Agarwal, MD
Indiana University School of Medicine, Indianapolis
Presentation: New targets for diabetic kidney disease
Date: November 18, 2016
George Bakris, MD
University of Chicago Pritzker School of Medicine, Illinois
Presentation: Aldosterone antagonists as treatment for diabetic albuminuria
Date: November 20, 2016
Jeffrey Berns, MD
University of Pennsylvania, Philadelphia
Presentation: Update from ABIM
Date: November 16, 2016

Previous Coverage

Related Resource